Crossmark

Mammalian prions and their wider relevance in neurodegenerative diseases

Crossref DOI link: https://doi.org/10.1038/nature20415

Published Online: 2016-11-09

Published Print: 2016-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Collinge, John
License Information

Text and Data Mining valid from 2016-11-01
More Information

Article History

Received: 8 June 2016

Accepted: 9 September 2016

First Online: 9 November 2016

Competing interests

: J.C. is a director and shareholder of D-Gen Limited, an academic spin-out company working the field of prion-disease diagnosis, decontamination and therapy.